Pfizer And BioNTech Begin Phase 1/2 Trial Of First-In-Class mRNA-Based Shingles Vaccine Program

https://investors.biontech.de/de/news-releases/news-release-details/pfizer-und-biontech-beginnen-phase-12-studie-mit-erstem-mrna

https://investors.biontech.de/de/news-releases/news-release-details/pfizer-und-biontech-beginnen-phase-12-studie-mit-erstem-mrna

Total
0
Shares
Related Posts
Read More

Recap: AudioCodes Q2 Earnings

  AudioCodes (NASDAQ:AUDC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 02:00 AM. Here's what investors need to know about the announcement. Earnings AudioCodes reported in-line EPS of $0.34 versus an estimate of $0.34.

AUDC